期刊文献+

地塞米松对骨髓基质干细胞体外增殖的影响 被引量:4

Effect of dexamethasone on the proliferation of bone marrow stem cells in vitro
下载PDF
导出
摘要 目的观察地塞米松对小鼠骨髓基质干细胞体外增殖的作用。方法取雄性6周龄ICR小鼠股骨骨髓基质细胞进行体外培养,在细胞培养不同时间点加入10-8mol/L地塞米松(实验组)或保持基础培养条件(对照组),用CellTiter方法分别检测两组的细胞增殖情况,并予比较。结果在细胞培养不同阶段开始应用地塞米松的实验组中,细胞增殖能力较对照组降低,随着培养时间延长实验组细胞数量明显少于对照组。实验组中细胞形态较对照组更趋成熟。结论地塞米松在促进骨髓干细胞定向分化早期抑制骨髓基质干细胞体外增殖。 Objective To study the mechanism of stem cells proliferation using dexamethasone-induced mouse bone marrow culture system. Methods Bone marrow cells were derived from 6-week-old ICR mice. Dexamethasone was initiated in experimental group at different time in the cultures. The control group was treated with placebo. Cell number was counted and compared between the two groups by CellTiter kit. Results The number of cells in the experimental group was significantly less than that in the control group at every time points. Much more cell differentiation was observed in'the experimental groups. Conclusion Dexamethasone inhibits stromal cell proliferation while stimulates osteoblast differentiation.
出处 《中国骨质疏松杂志》 CAS CSCD 2006年第5期452-454,共3页 Chinese Journal of Osteoporosis
基金 国家自然科学基金资助项目(30440077)
关键词 骨髓基质干细胞 成骨细胞 地塞米松 细胞增生 细胞分化 Bone marrow stem cell Osteoblast Dexamethasone Cell proliferation Cell differentiation
  • 相关文献

参考文献9

  • 1Pittenger MF,Mackay AM,Beck SC,et al.Multilineage potential of adult human mesenchymal stem cells.Science,1999,284:143-147.
  • 2Owen M,Friendenstein AJ.Stromal stem cells:marrow-derived osteogenic precursors.Ciba Found Symp,1988,136:42-60.
  • 3Qu Q,Pera-Heape M,Kapanen A,et al.Estrogen enhances differentiation of osteoblasts in mouse bone marrow culture.Bone,1998,22:201-209.
  • 4曲强,万新海,陈翠珠.转录因子cbfa1在骨髓干细胞向成骨细胞分化过程中的表达[J].中华实验外科杂志,2003,20(3):257-258. 被引量:4
  • 5Cheng SL,Yang JW,Rifas L,et al.Differentiation of human bone marrow osteogenic stromal cells in vitro:induction of the osteoblast phenotype by dexamethasone.Endocrinology,1994,134:277-286.
  • 6Kasperk C,Schneider U,Sommer F,et al.Differential effects of glucocorticoids on human osteoblastic cell metabolism in vitro.Calcif Tissue Int,1995,57:120-126.
  • 7Suarez F,Silve C.Effect of parathyroid hormone on arachidonic acid metabolism in mouse osteoblasts:Permissive action of dexamethasone.Endocrinology,1992,130:592-598.
  • 8Boden S,Mccuaig K,Hair G,et al.Differential effects and glucocorticoid potentiation of bone morphogenetic protein action during rat osteoblast differentiation in vitro.Endocrinology,1996,137:3401-3407.
  • 9陈翠珠,曲强.瘦素在骨髓基质干细胞向成骨细胞分化早期的作用研究[J].中国骨质疏松杂志,2004,10(2):158-161. 被引量:7

二级参考文献11

  • 1Gordeladze JO, Drevon CA, Syversen U, et al. Leptin stimulates human osteoblastic cell proliferation, de novo collagen synthesis, and mineralization: impact on differentiation markers, apoptosis, and osteoclastic signaling. J Cell Biochem, 2002, 85: 825-8
  • 2Pittenger MF, Mackay AM, Beck SC, et al. Multialineage potential of adult human mesenchymal stem cells. Science, 1999, 284:143-147.
  • 3Steppan CM, Crawford DT, Chidsey-Frink KL, et al. Leptin is a potent stimulator of bone growth in ob/ob mice. Regul Pept,2000, 92 (1-3):73-78.
  • 4Matkovic V, Ilich JZ, Skugor M, et al. Leptin is inversely related to age at menarche in human females. J Clin Endocrinol Metab, 1997, 82:3239-3245.
  • 5Ducy P, Amling M, Takeda S, et al. Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell,2000, 100:197-207.
  • 6Thomas T, Gori F, Khosla S, et al. Leptin acts on human marrow stromal cells to enhance differentiation to osteoblasts and to inhibit different iation to adipocytes. Endocrinology, 1999 140:1630-1638.
  • 7Qu Q, Pera-Heape M, Kapanen A, et al. Estrogen enhances differentiation of osteoblasts in mouse bone marrow culture. Bone, 1998, 22: 201209.
  • 8Zhang Y, Proenca R, Maffei M, et al. 1994 Position cloning of the mouse obese gene and its human homologue. Nature, 372: 425-432.
  • 9Couce ME, Burguera B, Parisi JE, et al. Localization of the leptin receptor in the human brain. Neuroendocrinology, 1997, 66:145-150.
  • 10Elefteriou F, Takeda S, Ebihara K, et al. Serum leptin level is a regulator of bone mass. Proc Natl Acad Sci,2004, 101:3258-3263.

共引文献9

同被引文献52

引证文献4

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部